Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Use of glycoproteome profiles to detect advanced adenomas and colorectal cancer.
Authors
Khushbu Desai
InterVenn Biosciences, South San Francisco, CA;
Khushbu Desai , Alan Mitchell , Ankita Shah , Dharini Chandrasekar , Gege Xu , Klaus Lindpaintner , Dan Serie , Tillman E. Pearce , Daniel Hommes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Clinical Trial Registration Number
NCT05445570
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 69)
DOI
10.1200/JCO.2023.41.4_suppl.69
Abstract #
69
Poster Bd #
D6
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Diagnostic application of circulating CDH17 biomarker for screening GI malignancies.
First Author: Lui Ng
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical performance of a multimodal screening blood test for advanced adenomas and CRC in an average-risk cohort of 1,038 participants.
First Author: Shai Friedland
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Novel blood-based biomarker candidates in screening for colorectal cancer.
First Author: Jason Lee Liggett
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Next-generation whole blood transcriptome-based assay for advanced adenoma detection.
First Author: Sahar Hosseinian Ehrensberger